Margaret G. Mcglynn
DirectoratNovavax· In the 2025 proxy
Margaret G. Mcglynn sits on 2 public boards.
Experience
- NovavaxPublic company · 1 yr
- Director2025 – Present · 1 yrStock in role +21%
- Brii Biosciences (Nasdaq: BRIBF)Public company
- Director? – PresentNo stock prices for these years
- Corcept Therapeutics (Nasdaq: CORT)Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?